[HTML][HTML] SARS-CoV-2 mutations and their impact on diagnostics, therapeutics and vaccines
S Thakur, S Sasi, SG Pillai, A Nag, D Shukla… - Frontiers in …, 2022 - frontiersin.org
With the high rate of COVID-19 infections worldwide, the emergence of SARS-CoV-2
variants was inevitable. Several mutations have been identified in the SARS-CoV-2 …
variants was inevitable. Several mutations have been identified in the SARS-CoV-2 …
Placental histopathology after SARS-CoV-2 infection in pregnancy: a systematic review and meta-analysis
R Di Girolamo, A Khalil, S Alameddine… - American journal of …, 2021 - Elsevier
OBJECTIVE This study aimed to report the spectrum of placental pathology findings in
pregnancies complicated by SARS-CoV-2 infection. DATA SOURCES MEDLINE, Embase …
pregnancies complicated by SARS-CoV-2 infection. DATA SOURCES MEDLINE, Embase …
Unwinding circular RNA's role in inflammatory pulmonary diseases
Circular RNAs (circRNAs) have emerged as pivotal regulators of gene expression and
cellular processes in various physiological and pathological conditions. In recent years …
cellular processes in various physiological and pathological conditions. In recent years …
Determinants of parental hesitancy to vaccinate their children against COVID-19 in China
MX Zhang, XQ Lin, Y Chen, TH Tung… - Expert Review of …, 2021 - Taylor & Francis
Vaccine hesitancy seriously hinders herd immunity. We explored the determinants of
parental hesitancy to vaccinate children against Coronavirus Disease 2019 (COVID-19) in …
parental hesitancy to vaccinate children against Coronavirus Disease 2019 (COVID-19) in …
OMICRON: Virology, immunopathogenesis, and laboratory diagnosis
M Bazargan, R Elahi… - The Journal of Gene …, 2022 - Wiley Online Library
Since its emersion, coronavirus disease 2019 (COVID‐19) has been a significant global
dilemma. Several mutations in the severe acute respiratory virus (SARS‐Co‐2) genome has …
dilemma. Several mutations in the severe acute respiratory virus (SARS‐Co‐2) genome has …
COVID‐19 in early 2023: Structure, replication mechanism, variants of SARS‐CoV‐2, diagnostic tests, and vaccine & drug development studies
Abstract Coronavirus Disease‐19 (COVID‐19) is an infectious disease caused by severe
acute respiratory syndrome‐coronaviruses‐2 (SARS‐CoV‐2), a highly pathogenic and …
acute respiratory syndrome‐coronaviruses‐2 (SARS‐CoV‐2), a highly pathogenic and …
[HTML][HTML] Basophils and mast cells in COVID-19 pathogenesis
G Murdaca, M Di Gioacchino, M Greco, M Borro… - Cells, 2021 - mdpi.com
Basophils and mast cells are among the principal inducers of Th2 responses and have a
crucial role in allergic and anti-parasitic protective immunity. Basophils can function as …
crucial role in allergic and anti-parasitic protective immunity. Basophils can function as …
Associations between Serum Interleukins (IL‐1β, IL‐2, IL‐4, IL‐6, IL‐8, and IL‐10) and Disease Severity of COVID‐19: A Systematic Review and Meta‐Analysis
Y Chang, M Bai, Q You - BioMed Research International, 2022 - Wiley Online Library
Background. To investigate the association between interleukins (IL‐1β, IL‐2, IL‐4, IL‐6, IL‐
8, and IL‐10) and the disease severity of coronavirus disease 2019 (COVID‐19). Materials …
8, and IL‐10) and the disease severity of coronavirus disease 2019 (COVID‐19). Materials …
[HTML][HTML] Efficacy of a Probiotic Consisting of Lacticaseibacillus rhamnosus PDV 1705, Bifidobacterium bifidum PDV 0903, Bifidobacterium longum subsp. infantis PDV …
V Ivashkin, V Fomin, S Moiseev, M Brovko… - Probiotics and …, 2021 - Springer
The treatment of coronavirus disease (COVID-19) and COVID-19-associated diarrhea
remains challenging. This study aimed to evaluate the efficacy of a multi-strain probiotic in …
remains challenging. This study aimed to evaluate the efficacy of a multi-strain probiotic in …
Predictive value of systemic immune-inflammation index and neutrophil-to-lymphocyte ratio in patients with severe COVID-19
W Xia, Y Tan, S Hu, C Li… - Clinical and Applied …, 2022 - journals.sagepub.com
Objective: It was initially reported that a novel coronavirus (COVID-19) had been identified in
Wuhan, China, in December 2019. To date, COVID-19 is still threatening all humanity and …
Wuhan, China, in December 2019. To date, COVID-19 is still threatening all humanity and …